32
Participants
Start Date
August 20, 2024
Primary Completion Date
October 29, 2024
Study Completion Date
November 14, 2024
IP
NX-5948 oral
Matching Placebo
Fluconazole
Celerion, Lincoln
Lead Sponsor
Nurix Therapeutics, Inc.
INDUSTRY